EpiBone is a revolutionary bone reconstruction company that allows patients to “grow their own bone”. EpiBone’s pioneering technology utilizes a scan of the patient’s bone defect and the patient’s own stem cells to construct and cultivate a defect-specific autologous-like bone graft. EpiBone is strategically positioned to provide a superior bone graft that will provide exact defect repair, a simplified surgical procedure, improved bone formation and regeneration, and shorter recovery times, without the complications of foreign body implantation, to the over 900,000 patients who undergo bone-related surgeries each year.
Looking for a particular EpiBone, Inc. employee's phone or email?
The EpiBone, Inc. annual revenue was $10 million in 2026.
Nina Tandon is the CEO, co-founder of EpiBone, Inc..
9 people are employed at EpiBone, Inc..
EpiBone, Inc. is based in Brooklyn, New York.
The NAICS codes for EpiBone, Inc. are [541713, 54, 541, 5417, 54171].
The SIC codes for EpiBone, Inc. are [87, 873].